Letters

Osteoporosis

BMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.6999.263 (Published 22 July 1995) Cite this as: BMJ 1995;311:263
  1. M Azria
  1. Head of calcitonin biology and safety Research and Development Division, Sandoz Pharmaceuticals, 4002 Basle, Switzerland

    EDITOR,--In their article on osteoporosis Nicola Peel and Richard Eastell state that “a nasal preparation [of calcitonin] …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe